1. Academic Validation
  2. Flavonifractor Plautii or Its Metabolite Desaminotyrosine as Prophylactic Agents for Alleviating Myocardial Ischemia/Reperfusion Injury

Flavonifractor Plautii or Its Metabolite Desaminotyrosine as Prophylactic Agents for Alleviating Myocardial Ischemia/Reperfusion Injury

  • Adv Sci (Weinh). 2025 Jun;12(21):e2417827. doi: 10.1002/advs.202417827.
Heng Du 1 2 Xu Liu 1 2 Jianghua Shen 1 2 Hailong Yuan 1 2 Hao Zhang 1 2 Gan Xi 2 3 Yujing Li 1 2 4 5 Yuhan Wang 1 2 4 5 Jiahe Zhang 1 2 4 5 Chaofan Yang 1 2 4 5 Pengfei Xu 1 2 4 5 Jiawan Wang 6 Fang Wang 1 4 Siqi Liu 1 2 4 5 Yanan Zhou 1 2 4 5 Qi Gu 1 2 4 5 Jingjing Lu 2 3 Tuo Wei 1 2 4 5 Zeyu Gao 1 5 Jingyi Zang 1 5 Jun Wang 2 3 Moshi Song 1 2 4 5
Affiliations

Affiliations

  • 1 State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.
  • 2 University of Chinese Academy of Sciences, Beijing, 100049, China.
  • 3 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Chinese Academy of Sciences, Beijing, 100101, China.
  • 4 Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, 100101, China.
  • 5 Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, 100101, China.
  • 6 Department of Anesthesiology, Beijing Chao-Yang Hospital, Beijing, 100020, China.
Abstract

Myocardial ischemia/reperfusion (I/R) injury is a major contributor to myocardial damage, leading to adverse cardiac remodeling and dysfunction. Recent studies have highlighted the potential of gut microbiota-derived metabolites in modulating cardiac outcomes. Here, the cardioprotective effects of a commensal bacterium Flavonifractor plautii (F. plautii) and its metabolite desaminotyrosine (DAT) against myocardial I/R injury are investigated. We showed that prophylactic gavage of F. plautii attenuates myocardial I/R injury as evidenced by improved cardiac function and reduced cardiac injury. We also found that its metabolite DAT recapitulates these cardioprotective effects against myocardial I/R injury. Transcriptomic analysis has revealed that DAT preserves cardiac tissue and attenuates immune responses against myocardial I/R injury. Mechanistically, DAT promotes cardiomyocyte survival through the modulation of the nicotinamide adenine dinucleotide phosphate (NADP+/NADPH) ratio. Further, DAT suppressed macrophage proinflammatory activities and cardiac inflammation via the reduction in interleukin-6 (IL-6) production. Taken together, our findings indicate that F. plautii and its metabolite DAT exert pleiotropic cardioprotective effects against myocardial I/R injury, suggesting them as potential prophylactic therapeutic options for alleviating myocardial I/R injury.

Keywords

Flavonifractor plautii; cardiac inflammation; cardiomyocyte survival; desaminotyrosine; myocardial ischemia/reperfusion injury.

Figures
Products